Ametanalysis showed that cotreatment with GnRH agonists can protect patientsfrom post-chemotherapy ovarian failure, but does not have an effect onpreserving fertility (Sun etal., 2014). The gene discussed is GNRH1; the disease is ovarian dysfunction.